A Global Leader in Regenerative Medicine
Liveyon entered the marketplace in 2016 with the ultimate goal of pushing the existing boundaries of regenerative medicine in all aspects of product research and development, manufacturing and distribution. Liveyon's dynamic ability to adapt to changing market trends and execute on opportunities has allowed for our exponential growth giving Liveyon recognition on a global scale.
Liveyon is now the most recognized stem cell brand in the world with distribution in the Middle East, Asia, Central and South America, as well as treatment centers and research agreements on nearly every continent, Liveyon has truly established itself as the global leader in the regenerative medicine space.
With a renowned team of world class scientist and clinicians backed by a full time, in-house regulatory team, Liveyon is entering the realm of clinical trials with Liveyon Labs’ industry leading PURE® Product...A clinical trial grade stem cell product made at Liveyon Labs’ cGMP Facility.

Why Liveyon Is Different 

Liveyon distributes umbilical cord derived products to physicians for use in regenerative medicine therapies. The umbilical cord is rich in growth factors and stem cells that have helped sustain the life of a healthy child for 9 months.

A Safe Product

We provide our customers with umbilical cord derived cells and growth factors that are ethically collected with informed consent. The cells are sourced from the umbilical cord of healthy donor volunteers painlessly and noninvasively. Each donor is carefully screened and tested for pathogens in order to assure the product is safe. In addition, there is presently no documentation of umbilical cord cells causing a malignancy or transforming into a malignant state following their use as a therapy.

These cells need no donor-patient matching as they are HLA-DR negative, and can be used for any patient with minimal to zero side effects. 

Easy For Physicians to Use

Liveyon Labs’ PURE® Product delivers uniform single doses with high cell-counts and consistent concentrations. The product can be applied according to your specific protocols or patients’ needs. Our regenerative medicine product can be delivered either cryopreserved on dry ice or in cryogenic dry vapor dewars. Our product is strictly compliant with FDA standards under Current Good Manufacturing Practice (cGMP) regulations. We take pride in the quality and reliability of our product. 

Consistent Concentrations for Precision and Control

From the beginning, our goal has been to provide doctors with the highest quality stem cell product. Our cells are safe, FDA-compliant, and easy to use. We deliver them directly to your medical practice in consistent concentrations for precise, controlled treatments.  

Specialties We Serve  

Liveyon serves a growing population of medical doctors who are choosing to include regenerative therapies in their practice. As research and clinical trials suggest an increasing array of benefits from the use of stem cells and other regenerative medicine products.
Translate »
 

 

Medical Professional Viewing Only (Disclaimer)


This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.
The FDA has stated:
Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.
http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194655.htm
This site is not intended for consumers.
If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.
“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.
If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm
Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.